Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    31 March 2025

    Goodwin Advised Harbour BioMed in $175 Million Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies

    The Life Sciences team advised Harbour BioMed on a global strategic collaboration with AstraZeneca to discover and develop next-generation multi-specific antibodies for immunology, oncology, and beyond. The strategic collaboration includes an option to license multiple programs u...

    3 June 2025

    STEMCELL Technologies announces acquisition of Cellular Highways

    Vancouver, British Columbia and Cambridge, United Kingdom, June 02, 2025 – STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge...

    18 July 2025

    Music therapy may reduce distress for people with dementia

    Research with CPFT finds that a new treatment approach using music therapy on NHS dementia wards could improve care and support for some of the most vulnerable NHS patients. ...

    23 July 2025

    Faster, more accessible clinical trial initiative being piloted in pancreatic cancer

    A pancreatic cancer trial led from Addenbrooke’s Hospital, Cambridge, is piloting a new scheme intended to make clinical trials faster and more accessible for patients in line with the NHS 10-year plan. ...

    9 July 2025

    Meeting of minds to tackle mental health and brain disorders

    More than 150 innovators and partners from across the country gathered in Cambridge on the 30th June to explore new, cutting-edge ways to tackle neurological and mental health conditions. These disorders will affect four in five of us in our lives and represent a greater overall health ...

    28 July 2025

    Navigating the UK life sciences talent landscape in 2025: Growth opportunities, key challenges and strategies for integrating Chinese expertise

    Disclaimer: This article is intended for industry professionals and provides general educational information only. It does not promote specific products or constitute medical advice.Market OverviewThe UK life sciences sector remains a cornerstone of the national economy, employing aro...

    1 August 2025

    Cambridge Innovation Capital commits £100m to back University of Cambridge spinouts

    New Entrepreneur in Residence programme matches serial entrepreneurs with academics to develop world-leading ideas and IP. ...

    1 August 2025

    UK perspective: Harnessing the power of global collaboration in Precision Oncology

    Disclaimer:The views expressed in this article reflect the professional perspective and experience of Excellence First Enterprise Consultancy Ltd (EFEC). This content is intended for informational purposes only and does not constitute commercial endorsement, medical advice, or solicit...

    5 August 2025

    Construction partner appointed for new Cambridge Children’s Hospital

    The Cambridge Children’s Hospital project has appointed Bouygues UK as its construction partner for a groundbreaking new hospital that will redefine how we care for children and young people. ...

    6 August 2025

    CPFT psychiatrist publishes book to guide person-centred care

    Dr Robert Dudas, consultant old age psychiatrist at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT), has edited and published a new book to support best practice for mental health care and recovery. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 68
    • Page 69
    • Current page 70
    • Page 71
    • Page 72
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS